Freenome, Inc. Unrealized Gain (Loss) on Investments
Freenome, Inc. (FRNM) reported Unrealized Gain (Loss) on Investments of -$951 for the 3-month period ending 2026-06-30, per its S-1 filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-18
- Freenome, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was -$951.00.
- Freenome, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was -$34.10K.
- Freenome, Inc. unrealized gain (loss) on investments for the quarter ending 2025-06-30 was -$879.00.
- Freenome, Inc. unrealized gain (loss) on investments for the quarter ending 2025-03-31 was -$27.40K.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$951.00 S-1 · filed 2026-08-18 | -$35.05K S-1 · filed 2026-08-18 | ||
| 2026-03-31 | -$34.10K S-4/A · filed 2026-06-11 | |||
| 2025-12-31 | -$3.30K S-1 · filed 2026-08-18 | |||
| 2025-06-30 | -$879.00 S-1 · filed 2026-08-18 | -$28.28K S-1 · filed 2026-08-18 | ||
| 2025-03-31 | -$27.40K S-4/A · filed 2026-06-11 | |||
| 2024-12-31 | $38.40K S-1 · filed 2026-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |